107 results
Page 4 of 6
6-K
EX-99.1
6dv4t93r8pre3nufp8
30 Sep 13
Live Filing
12:00am
6-K
cpmllzhw
18 Jul 13
Current report (foreign)
12:00am
6-K
EX-99
hoi3g9t ifk5
30 May 13
TEVA ANNOUNCES FDA ACCEPTANCE OF sNDA FOR A HIGHER CONCENTRATION DOSE OF COPAXONE®GIVEN THREE TIMES A WEEK
12:00am
6-K
EX-99.1
860s7q
25 Apr 13
Live Filing
12:00am
6-K
EX-99.1
4nfdce15h8 y85v
8 Apr 13
Teva-Handok Names Yoo Suk Hong as Chief Executive Officer
12:00am
6-K
EX-99.1
p90n5nt vv
17 Dec 12
Teva Enters Agreement with Handok to Establish Business Venture with Significant Presence in Korean Pharmaceutical Market
12:00am
6-K
veji7zsnglmi3v5t5
5 Dec 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
424B5
tyi gllbtc8dkmk2jv
8 Nov 11
Prospectus supplement for primary offering
12:00am
424B5
6ka55u2n9h8
7 Nov 11
Prospectus supplement for primary offering
12:00am
6-K
o3bz2ftb7ei7zohcn8m
24 Mar 11
the Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership
12:00am
424B5
t34xt6z78rgk474p
17 Mar 11
Prospectus supplement for primary offering
12:00am
424B5
i7tztiba j7p5h3l
16 Mar 11
Prospectus supplement for primary offering
12:00am
424B5
6wdd4avu4gpv
16 Jun 10
Prospectus supplement for primary offering
12:00am
F-3ASR
736tc8q84vuaj
4 Dec 08
Automatic shelf registration (foreign)
12:00am